TMEM265: A Drug Target / Disease Biomarker (G100862671)

Target Name: TMEM265

NCBI ID: G100862671

TMEM265

TMEM265: A Drug Target / Disease Biomarker

TMEM265 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family, which means that it is involved in the transfer of materials between the cell membrane and the cytoplasm. TMEM265 is also known as TMEM-T17 and has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TMEM265 is involved in a number of different cellular processes that are critical for the proper functioning of tissues. It plays a role in the regulation of ion and water transport, as well as in the maintenance of the cell membrane structure and stability. It is also involved in the formation of mitochondrial organelles, which are important for the production of energy by the cell.

One of the most promising aspects of TMEM265 is its potential as a drug target. TMEM265 has been shown to be involved in a variety of signaling pathways that are involved in the development and progression of cancer. For example, studies have shown that TMEM265 is involved in the regulation of the angiogenic factor, PDGF, which is a key factor in the development of cancer.

In addition to its involvement in cancer, TMEM265 is also thought to be involved in a number of other diseases and disorders. For example, it is involved in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It is also involved in the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Another promising aspect of TMEM265 is its potential as a biomarker. TMEM265 has been shown to be expressed in a variety of tissues and cells, including cancer cells, neurons, and glial cells. This makes it a potential source of diagnostic information for cancer, as well as a potential indicator of disease severity and response to treatment.

TMEM265 is also thought to be involved in the regulation of a variety of physiological processes that are important for the survival and proper functioning of the body. For example, it is involved in the regulation of blood pressure and heart rate, as well as in the regulation of the production of hormones that control hunger and appetite.

In conclusion, TMEM265 is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes that are critical for the proper functioning of tissues. Its potential as a drug target or biomarker for various diseases makes it an attractive target for further research and development. Further studies are needed to fully understand the role of TMEM265 in these diseases and to determine its potential as a therapeutic agent.

Protein Name: Transmembrane Protein 265

The "TMEM265 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM265 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets